Article Text
Abstract
Objectives To examine whether the extent of fibroproliferative changes on high-resolution CT (HRCT) scan influences prognosis, ventilator dependency and the associated outcomes in patients with early acute respiratory distress syndrome (ARDS).
Design A prospective observational cohort study.
Setting Intensive care unit in a teaching hospital.
Participants 85 patients with ARDS who met American-European Consensus Conference Criteria and eligible criteria.
Interventions HRCT scans were performed and prospectively evaluated by two independent observers on the day of diagnosis and graded into six findings according to the extent of fibroproliferation. An overall HRCT score was obtained by previously published method.
Primary and secondary outcomes The primary outcome was 60-day mortality. Secondary outcomes included the number of ventilator-free days, organ failure-free days, the incidence of barotraumas and the occurrence of ventilator-associated pneumonia.
Results Higher HRCT scores were associated with statistically significant decreases in organ failure-free days as well as ventilator-free days. Multivariate Cox proportional hazards model showed that the HRCT score remained an independent risk factor for mortality (HR 1.20; 95% CI 1.06 to 1.36; p=0.005). Multivariate analysis also revealed that the CT score had predictive value for ventilator weaning within 28 days (OR 0.63; 95% CI 0.48 to 0.82; p=0.0006) as well as for an incidence of barotraumas (OR 1.61; 95% CI 1.08 to 2.38; p=0.018) and for an occurrence of ventilator-associated pneumonia (OR 1.46; 95% CI 1.13 to 1.89; p=0.004). A HRCT score <210 enabled prediction of 60-day survival with 71% sensitivity and 72% specificity and of ventilator-weaning within 28 days with 75% sensitivity and 76% specificity.
Conclusions Pulmonary fibroproliferation assessed by HRCT in patients with early ARDS predicts increased mortality with an increased susceptibility to multiple organ failure, including ventilator dependency and its associated outcomes.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
Statistics from Altmetric.com
Supplementary materials
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data Supplement - Manuscript file of format pdf
Footnotes
To cite: Ichikado K, Muranaka H, Gushima Y, et al. Fibroproliferative changes on high-resolution CT in the acute respiratory distress syndrome predict mortality and ventilator dependency: a prospective observational cohort study. BMJ Open 2012;2:e000545. doi:10.1136/bmjopen-2011-000545
Contributors MS takes full responsibility for the integrity of all the data and the accuracy of the data analysis. KI contributed to designing the study, collecting the data, analysing the data and writing the manuscript. HM contributed to collecting data, analysing the data and revising the manuscript. YG contributed to collecting data, analysing the data and revising the manuscript. TK contributed to analysing the data and revising the manuscript. HMN contributed to reanalysing the data and revising the manuscript. KF, TJ, NI, KK, JN, KF, NH, TY, HI, ST, HK, AK, MY and TS contributed to reanalysing the data and revising the manuscript. Other persons contributing to this study: we appreciate Michael A Matthay (Departments of Medicine and Anesthesia, University of California, San Francisco, CA, USA) and Hiroshi Kubo (Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, Tohoku University, Sendai City, Miyagi, Japan) for their editorial assistance and also thank Isamu Cho (Pulmonary Division, Kumamoto City Hospital, Kumamoto City, Japan), Tomoki Tanaka (Pulmonary Division, Kumamoto City Hospital, Kumamoto City, Japan), Junichi Maehara (Department of Emergency and Critical Care Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan), Shigeo Hiroshige (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan), Makoto Takaki (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan), Mitsuko Honda (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan), Naoko Arakawa (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan), Yuko Yasuda (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan), Makiko Takeguchi (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan), Aoi Teruya (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan), Yoshitomo Eguchi (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan), Naoki Shingu (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan), Yoshihiko Sakata (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan) and Azusa Katsume (Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan) for their clinical assistance.
Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None.
Ethics approval This study was approved by an institutional review board of our hospital.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement There are no additional data available.